Appendix 4C & Quarterly Business Update – March 2024
30 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
Quarterly Business Update; Launching our most comprehensive test and expanding into new global markets
Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering
22 avr. 2024 15h00 HE
|
Genetic Technologies Ltd
Genetic Technologies Announces Closing of $2 Million Registered Direct Offering
Genetic Technologies Announces $2 Million Registered Direct Offering
18 avr. 2024 12h17 HE
|
Genetic Technologies Ltd
Genetic Technologies Announces $2 Million Registered Direct Offering
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
17 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
New Precision Oncology Tests to Drive Personalised Therapies and Improved Treatment Outcomes
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
16 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
GeneType Clinicians’ Adoption Growing - Sales up 5-Fold Year on Year
GTG to pilot GeneType in Breast Screen centers across the U.S.
11 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
Genetic Technologies to pilot GeneType in Breast Screen centers across the U.S.
EVENT - Empowering Women Through Knowledge; Humanise Health & GeneType Launch "Know Your Risk”
08 avr. 2024 08h00 HE
|
Genetic Technologies Ltd
Humanise Health & GeneType and launch "Know Your Risk" event
Genetic Technologies’ Digital Strategy Ignites Significant Traction in US Market
02 avr. 2024 08h05 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, April 02, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GTG Global Collaborations and Innovation Update
26 mars 2024 08h00 HE
|
Genetic Technologies Ltd
GTG Global Collaborations and Innovation Update
GENE to develop Worlds Most Advanced Comprehensive Risk Test Revolutionising Personalised Healthcare
25 mars 2024 08h00 HE
|
Genetic Technologies Ltd
MELBOURNE, Australia, March 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, “Company”, “GENE”), a global leader in guideline-driven genomics-based testing in health, wellness...